SESHADRI VISHWAS (SVP, Head of Res./Clin. Dev.) sold 3.9% of their position (56.34K shares) of ABEONA THERAPEUTICS INC. on the open market
Open‑market sale worth $301.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/10/2026ACC: 0001493152-26-028020
Officer· SVP, Head of Res./Clin. Dev.
Since Jun 2021
-56.34K
Net shares
Net seller
$301.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
56.34K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−24.43K
Price / share
$5.43
Trade value
$132.63K
% of position
1.7%
6/8/2026
1.43M→1.41M
Common Stock
Direct
Shares
−31.92K
Price / share
$5.30
Trade value
$169.29K
% of position
2.3%
6/9/2026
1.41M→1.37M
Total
Net shares
−56.34K
Net value
-$301.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/8/2026 | S · Sale | −24.43K | $5.43 | $132.63K | 1.7% | 1.43M | 1.41M |
| Common Stock Direct | 6/9/2026 | S · Sale | −31.92K | $5.30 | $169.29K | 2.3% | 1.41M | 1.37M |
| Total | −56.34K | -$301.92K | ||||||
Derivative Transactions0
No derivative transactions reported